(READ) FDA approves new, weekly weight loss drug

The FDA has approved a new, under-the-skin injection called semaglutide for weight loss. That’s according to Medscape. Semaglutide induces weight loss by reducing hunger, increasing feelings of fullness, and thereby helping people eat less and reduce their calorie intake  Novo Nordisk company announcement The drug will be sold in the U.S. as “Wegovy.” According to […]

Continue reading (READ) FDA approves new, weekly weight loss drug on sharylattkisson.com.